(Q34283715)

English

Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects (English)

1 reference

Europe PubMed Central

1 August 2017

post-traumatic stress disorder

0 references

1 reference

based on heuristic

inferred from title

Dolores Malaspina

9

object named as

Dolores Malaspina

1 reference

Europe PubMed Central

1 August 2017

author name string

Frederic J Sautter

1

1 reference

Europe PubMed Central

1 August 2017

Garth Bissette

2

1 reference

Europe PubMed Central

1 August 2017

Justin Wiley

3

1 reference

Europe PubMed Central

1 August 2017

Gina Manguno-Mire

4

1 reference

Europe PubMed Central

1 August 2017

Benjamin Schoenbachler

5

1 reference

Europe PubMed Central

1 August 2017

Leann Myers

6

1 reference

Europe PubMed Central

1 August 2017

Janet E Johnson

7

1 reference

Europe PubMed Central

1 August 2017

Arleen Cerbone

8

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

1 August 2017

Biological Psychiatry

1 reference

Europe PubMed Central

1 August 2017

54

1 reference

Europe PubMed Central

1 August 2017

12

1 reference

Europe PubMed Central

1 August 2017

1382-1388

1 reference

Europe PubMed Central

1 August 2017

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Positive symptoms of psychosis in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychobiologic mechanisms of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychotic symptoms in combat-related posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychotic features and combat-associated PTSD

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

The corticosteroid receptor hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Posttraumatic stress disorder in a general psychiatric inpatient population.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Auditory hallucinations in combat-related chronic posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Dexamethasone increases plasma free dopamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

PTSD and comorbid psychotic disorder: comparison with veterans diagnosed with PTSD or psychotic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Family history study of posttraumatic stress disorder with secondary psychotic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

The corticotropin-releasing hormone test in patients with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Auditory hallucinations, posttraumatic stress disorder, and ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Dexamethasone increases plasma HVA but not MHPG in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

Trauma and posttraumatic stress disorder in severe mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900571-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(03)00571-7

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34283715&oldid=1545181084"